Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study-Reference-Cited by-同舟云学术

Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study

Published:2014-02 Issue:9915 Volume:383 Page:436-448
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Güngör Tayfun,Teira Pierre,Slatter Mary,Stussi Georg,Stepensky Polina,Moshous Despina,Vermont Clementien,Ahmad Imran,Shaw Peter J,da Cunha José Marcos Telles,Schlegel Paul G,Hough Rachel,Fasth Anders,Kentouche Karim,Gruhn Bernd,Fernandes Juliana F,Lachance Silvy,Bredius Robbert,Resnick Igor B,Belohradsky Bernd H,Gennery Andrew,Fischer Alain,Gaspar H Bobby,Schanz Urs,Seger Reinhard,Rentsch Katharina,Veys Paul,Haddad Elie,Albert Michael H,Hassan Moustapha

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Chronic granulomatous disease: the European experience;van den Berg;PLoS One,2009

2. Chronic granulomatous disease. Report on a national registry of 368 patients;Winkelstein;Medicine (Baltimore),2000

3. Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen;Reichenbach;Clin Infect Dis,2009

4. Advances in the diagnosis and treatment of chronic granulomatous disease;Seger;Curr Opin Hematol,2011

5. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease;Meissner;Blood,2010

Cited by 321 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT);Bone Marrow Transplantation;2024-09-13

2. Clinical presentation, diagnosis, and treatment of chronic granulomatous disease;Frontiers in Pediatrics;2024-06-28

3. High-dose individualized antithymocyte globulin with therapeutic drug monitoring in high-risk cord blood transplant;Cytotherapy;2024-06

4. Chronic granulomatous disease: A single-center experience in Central Anatolia;Pediatrics & Neonatology;2024-06

5. Infectious complications in the paediatric immunocompromised host: a narrative review;Clinical Microbiology and Infection;2024-06